Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 1.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000E65 | John M. Kirkwood [États-Unis] ; Lars Bastholt [Danemark] ; Caroline Robert [France] ; Jeff Sosman [États-Unis] ; James Larkin [Royaume-Uni] ; Peter Hersey [Australie] ; Mark Middleton [Royaume-Uni] ; Mireille Cantarini [Royaume-Uni] ; Victoria Zazulina [Royaume-Uni] ; Karin Kemsley [Royaume-Uni] ; Reinhard Dummer [Suisse] | Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma |
| This area was generated with Dilib version V0.6.33. |  |